2-chlorodeoxyadenosine (2-CdA) [cladribine] (Leustatin)

From Aaushi
Jump to navigation Jump to search

Introduction

Alias: cladribine. Tradename: Leustatin.

Indications

Dosage

Vials: 1 mg/mL, 10 mL.

Monitor

CBC especially during 1st 4-8 weeks post-treatment

Adverse effects

Drug interactions

More general terms

References

  1. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  2. Harrison's Principles of Internal Medicine, 14th ed. Fauci et al (eds), McGraw-Hill Inc. NY, 1998, pg 529
  3. Department of Veterans Affairs, VA National Formulary
  4. 4.0 4.1 4.2 Deprecated Reference
  5. 5.0 5.1 Dagogo-Jack I, Vaidya A, Geller B, Baden LR, Stone R. A Man with Fever, Cough and Rash N Engl J Med 2014 371:e11. August 21, 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25140977 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMimc1310796

Database